Clinical Trials Browser

Phase 2 × NSCLC × icotinib × Clear all

NCT02272127 2014-10-22

Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer

Phase 2 Unknown

NSCLC